WatchGov

Tennessee bills · 114th Regular Session (2025-2026)

Tennessee SB 1848

Controlled Substances - As enacted, authorizes additional healthcare providers to directly administer buprenorphine mono or buprenorphine without the use of naloxone; adds that prescribing a buprenorphine product to nursing mother or prescribing an injectable mono product does not restrict certain healthcare providers from prescribing a buprenorphine product for the treatment of opioid use disorder without naloxone. - Amends TCA Title 53, Chapter 11.

  1. Introduced
  2. In committee
  3. Passed Senate
  4. Passed House
  5. To Governor
  6. Became law

Sponsors

Summary

No official summary is available for this bill.

Latest action(Apr 24, 2026): Comp. became Pub. Ch. 753

Read the official text

Text versions

Roll-call votes

State vote data last updated Oct 16, 2026, 12:24 AM.

DateVoteResultYour legislators
Mar 18, 2026
Senate
SENATE HEALTH AND WELFARE COMMITTEE: Recommended for passage, refer to Senate Calendar Committee 3/18/2026 Passed (1)passSet your home in Tennessee to see

Actions